Case Studies/Research/MGB BIOPHARMA LIMITED
Compulsory liquidation

MGB BIOPHARMA LIMITED

MGB BIOPHARMA LIMITED is tracked from The Gazette and Companies House public record. Compulsory liquidation proceedings were first recorded on 7 April 2026.

Key facts
Company no.SC362273
SectorResearch
Incorporated7 Jul 2009
Reg. officeEdinburgh EH2
Appointed7 Apr 2026
The timeline · incorporation → liquidation
7 Jul 2009
Incorporated
Registered as SC362273. Research.
28 Sep 2009
Board changes begin
First of the director resignations before failure.
9 Dec 2010
First accounts filed
change-account-reference-date-company-current-extended
29 Apr 2024
Latest accounts filed
accounts-with-accounts-type-total-exemption-full
7 Apr 2026
Wound up by the court
Compulsory liquidation.
7 Apr 2026
Gazette notice published
Notice 5102139 in The Gazette.

What the data was telling us

Readings from The Gazette and Companies House, in the firm's final two years.

Insolvency statusCompulsory
StatusCompulsory liquidation
Gazette refNotice 5102139
EditionThe Gazette
Appointed byThe court
UnderInsolvency Act 1986, s.122
Filing trajectoryLate filing
Incorporated7 Jul 2009
Last accounts29 Apr 2024
Confirmation stmtOverdue
Account typeFull
Director stabilityBoard churn
Appointments12 since 2009
Resignations0 in final 12 mths
Active directors4
DisqualificationsNone on record
Avg tenure7.0 yrs
The full forensic report

Every charge, every filing, every appointment, in one dossier.

Director histories across related entities, the full debenture instrument, creditor estimates, and the practitioner's record on comparable cases.